These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 11758761)
21. Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide. Bourasset F; Scherrmann JM Life Sci; 2006 Apr; 78(20):2302-14. PubMed ID: 16309712 [TBL] [Abstract][Full Text] [Related]
22. Prediction of methotrexate CNS distribution in different species - influence of disease conditions. Westerhout J; van den Berg DJ; Hartman R; Danhof M; de Lange EC Eur J Pharm Sci; 2014 Jun; 57():11-24. PubMed ID: 24462766 [TBL] [Abstract][Full Text] [Related]
23. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. Kakee A; Takanaga H; Terasaki T; Naito M; Tsuruo T; Sugiyama Y J Neurochem; 2001 Oct; 79(1):110-8. PubMed ID: 11595763 [TBL] [Abstract][Full Text] [Related]
24. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid. Kim HS; Min YD; Choi CH Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768 [TBL] [Abstract][Full Text] [Related]
25. Use of cultured cerebral capillary endothelial cells in modeling the central nervous system availability of 2',3'-dideoxyinosine. Johnson MD; Anderson BD J Pharm Sci; 2000 Mar; 89(3):322-35. PubMed ID: 10707013 [TBL] [Abstract][Full Text] [Related]
26. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
27. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Batrakova EV; Li S; Miller DW; Kabanov AV Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651 [TBL] [Abstract][Full Text] [Related]
28. Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis. Lindén K; Ståhle L; Ljungdahl-Ståhle E; Borg N Pharmacol Toxicol; 2003 Nov; 93(5):226-32. PubMed ID: 14629734 [TBL] [Abstract][Full Text] [Related]
29. Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. Masereeuw R; Moons MM; Toomey BH; Russel FG; Miller DS J Pharmacol Exp Ther; 1999 May; 289(2):1104-11. PubMed ID: 10215693 [TBL] [Abstract][Full Text] [Related]
30. Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance. Cao C; Steinberg TH; Neu HC; Cohen D; Horwitz SB; Hickman S; Silverstein SC Infect Agents Dis; 1993 Aug; 2(4):193-200. PubMed ID: 7909709 [TBL] [Abstract][Full Text] [Related]
31. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. Bourasset F; Cisternino S; Temsamani J; Scherrmann JM J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465 [TBL] [Abstract][Full Text] [Related]
32. Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier. Bousquet L; Roucairol C; Hembury A; Nevers MC; Creminon C; Farinotti R; Mabondzo A AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1147-54. PubMed ID: 18729774 [TBL] [Abstract][Full Text] [Related]
33. Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis. Deguchi Y; Inabe K; Tomiyasu K; Nozawa K; Yamada S; Kimura R Pharm Res; 1995 Dec; 12(12):1838-44. PubMed ID: 8786954 [TBL] [Abstract][Full Text] [Related]
34. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837 [TBL] [Abstract][Full Text] [Related]
35. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis. Wong SL; Van Belle K; Sawchuk RJ J Pharmacol Exp Ther; 1993 Feb; 264(2):899-909. PubMed ID: 8437131 [TBL] [Abstract][Full Text] [Related]
36. Zidovudine transport within the rabbit brain during intracerebroventricular administration and the effect of probenecid. Wang Y; Wei Y; Sawchuk RJ J Pharm Sci; 1997 Dec; 86(12):1484-90. PubMed ID: 9423165 [TBL] [Abstract][Full Text] [Related]
37. Identification of an organic anion transport system in the human colon carcinoma cell line HT29 clone 19A. Abrahamse SL; Rechkemmer G Pflugers Arch; 2001 Jan; 441(4):529-37. PubMed ID: 11212217 [TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Bachmeier CJ; Spitzenberger TJ; Elmquist WF; Miller DW Pharm Res; 2005 Aug; 22(8):1259-68. PubMed ID: 16078135 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats. Potschka H; Baltes S; Löscher W Epilepsy Res; 2004 Feb; 58(2-3):85-91. PubMed ID: 15120740 [TBL] [Abstract][Full Text] [Related]
40. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies. Hesselink MB; Smolders H; Eilbacher B; De Boer AG; Breimer DD; Danysz W J Pharmacol Exp Ther; 1999 Aug; 290(2):543-50. PubMed ID: 10411561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]